冠状动脉硬化心脏病伴高血压患者心房颤动发生的危险因素及临床特点探讨

Risk factors and clinical characteristics of atrial fibrillation in patients with coronary atherosclerotic heart disease and hypertension

目的探讨冠状动脉硬化心脏病伴高血压患者心房颤动发生的危险因素及临床特点。方法回顾性分析2019年1—12月本院收治的348例冠状动脉硬化心脏病伴高血压疾病患者的临床资料,依据是否伴有心房颤动情况分为研究组(合并心房颤动,n=26)和对照组(无心房颤动,n=322)。比较两组基本资料、血压及心脏等相关指标,Logistic回归分析患者合并心房颤动的影响因素。结果研究组年龄、左心室收缩末期容积(LVESV)、左心室舒张末期容积(LVEDV)及左心房内径(LA)高于对照组,左心室射血分数(LVEF)和左室短轴缩短率(FS)低于对照组,差异有统计学意义(P<0.05)。Logistic回归分析显示,年龄、LA是患者合并心房颤动情况的危险因素(P<0.05)。结论冠状动脉硬化心脏病伴高血压患者中年龄与LA是诱发其心房颤动情况出现的危险因素,应加强对合并上述情况者的监护,若患者出现心房颤动应给予及时有效处理,防止因心房颤动而继发不良后果情况出现。

Objective To explore the risk factors and clinical characteristics of atrial fibrillation in patients with coronary arteriosclerosis heart disease and hypertension.Methods The clinical data of 348 patients with coronary atherosclerotic heart disease accompanied by hypertension admitted to our hospital from January to December 2019 were retrospectively analyzed,they were divided into study group(with atrial fibrillation,n=26)and control group(without atrial fibrillation,n=322)based on whether they were accompanied by atrial fibrillation.Basic data,blood pressure,heart and other related indicators were compared between the two groups,and the influencing factors of patients with atrial fibrillation were analyzed by Logistic regression.Results The age,left ventricular end-systolic volume(LVESV),left ventricular end-diastolic volume(LVEDV)and left atrial diameter(LA)of the study group were higher than those of the control group,while the left ventricular ejection fraction(LVEF)and left ventricular short-axis shortening rate(FS)of the study group were lower than those of the control group,the difference was statistically significant(P<0.05).Logistic regression analysis showed that age and LA were risk factors for patients with atrial fibrillation(P<0.05).Conclusion Age and LA are risk factors for the occurrence of atrial fibrillation in patients with coronary arteriosclerosis heart disease and hypertension.It is necessary to strengthen monitoring of patients with these conditions.If patients experience atrial fibrillation,timely and effective treatment should be given to prevent the occurrence of secondary adverse consequences due to atrial fibrillation.